Another study revealed an incline in several distinct β1,6-branched N-glycans (produced by the action GnT-V) and a decline in some hybrid type N-glycans (produced by decreased activity of GnT-II) in cells derived from high risk neuroblastoma (NLF) relative to cells derived from low risk neuroblastoma (SY5Y) [12]. This evidence concerns the gene MGAT5 and neuroblastoma.